Industries We Serve: Pharma, Biotech, Rare Disease

Industries

The same three products, set up differently depending on who is using them. A global pharma company, a pre-launch biotech and a rare disease franchise face different versions of the same problem: too many places to look, too little time, and a picture nobody shares. These pages describe how each one uses the platform.

Pharma and Life Sciences

One current picture for medical, commercial and data teams

A pharmaceutical company runs on information that lives in too many places. The medical organization follows the science and the experts.

Biotech

For small teams that have to see everything

In a biotech, the person responsible for medical affairs may also be the competitive intelligence function, the congress planner and the one who briefs the board on what the competition is doing. There is no team of analysts to assemble the weekly update.

Specialty and Rare Disease

Few patients, few experts, no room for a missed signal

Specialty and rare disease brands are built on relationships with a small number of experts, a literature that is thin but consequential, and access decisions that can decide the brand's year. The teams are small and the stakes are high.